期刊
OPHTHALMOLOGY
卷 121, 期 7, 页码 1350-1358出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ophtha.2014.01.017
关键词
-
资金
- Nidek
- Carl-Zeiss Meditec
- Heidelberg Engineering
- Topcon, Inc.
- Topcon
- Zeiss Meditec
- Alcon
- Allergan
- Bausch Lomb
- Alcon Laboratories
- Allergan, Inc
- Diopsys Corporation
- Glaukos Corporation
- Merz Pharmaceutical, Inc
- Optovue, Inc
- Quark Pharmaceuticals, Inc
- SOLX, Inc.
- Carl Zeiss Meditech, Inc
- National Eye Institute, National Institutes of Health, Bethesda, Maryland [P30EY022589, U10EY14267, EY019869, EY021818, EY022039, EY08208, EY11008, EY13959]
- Eyesight Foundation of Alabama, Birmingham, AL
- Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, New York
- Japan Eye Bank Association, Tokyo, Japan (Overseas Research Grant)
- Research to Prevent Blindness, Inc., New York, New York
- Carl Zeiss Meditech
Purpose: To compare the rates of retinal nerve fiber layer (RNFL) loss in patients suspected of having glaucoma who developed visual field damage (VFD) with those who did not develop VFD and to determine whether the rate of RNFL loss can be used to predict the development of VFD. Design: Prospective, observational cohort study. Participants: Glaucoma suspects, defined as having glaucomatous optic neuropathy or ocular hypertension (intraocular pressure, >21 mmHg) without repeatable VFD at baseline, from the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. Methods: Global and quadrant RNFL thickness (RNFLT) were measured with the Spectralis spectral-domain optical coherence tomography (SD-OCT; Spectralis HRA+OCT [Heidelberg Engineering, Heidelberg, Germany]). Visual field damage was defined as having 3 consecutive abnormal visual fields. The rate of RNFL loss in eyes developing VFD was compared to eyes not developing VFD using multivariate linear mixed-effects models. A joint longitudinal survival model used the estimated RNFLT slope to predict the risk of developing VFD, while adjusting for potential confounding variables. Main Outcome Measures: The rate of RNFL thinning and the probability of developing VFD. Results: Four hundred fifty-four eyes of 294 glaucoma suspects were included. The average number of SDOCT examinations was 4.6 (range, 2-9), with median follow-up of 2.2 years (0.4-4.1 years). Forty eyes (8.8%) developed VFD. The estimated mean rate of global RNFL loss was significantly faster in eyes that developed VFD compared with eyes that did not develop VFD (-2.02 mu m/year vs. -0.82 mu m/year; P < 0.001). The joint longitudinal survival model showed that each 1-mu m/year faster rate of global RNFL loss corresponded to a 2.05-times higher risk of developing VFD (hazard ratio, 2.05; 95% confidence interval, 1.14-3.71; P = 0.017). Conclusions: The rate of global RNFL loss was more than twice as fast in eyes that developed VFD compared with eyes that did not develop VFD. A joint longitudinal survival model showed that a 1-mm/year faster rate of RNFLT loss corresponded to a 2.05-times higher risk of developing VFD. These results suggest that measuring the rate of SD-OCT RNFL loss may be a useful tool to help identify patients who are at a high risk of developing visual field loss. (C) 2014 by the American Academy of Ophthalmology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据